A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

Abstract

These preliminary data support further development of investigational idursulfase-IT in MPS II patients with the severe phenotype who have progressed only to a mild-to-moderate level of cognitive impairment.Genet Med 18 1, 73-81.